NHS England, Biogen reach deal on pricey drug for deadly disorder

75

England’s National Health Service said it had reached a deal to pay for U.S. drugmaker Biogen Inc’s expensive spinal muscle atrophy treatment Spinraza.

http://feeds.reuters.com/~r/reuters/healthNews/~3/hcieYahMcFE/nhs-england-biogen-reach-deal-on-pricey-drug-for-deadly-disorder-idUSKCN1SK2QN

- Advertisement -